Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With Breast Cancer-Reference-Cited by-同舟云学术

Prognostic Role of Early and End-of-Neoadjuvant Treatment 18F-FDG PET/CT in Patients With Breast Cancer

Published:2016-07 Issue:7 Volume:41 Page:e313-e322
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

García Vicente Ana María,Amo-Salas Mariano,Relea Calatayud Fernanda,Muñoz Sánchez María del Mar,Pena Pardo Francisco José,Jiménez Londoño Germán Andrés,Álvarez Cabellos Ruth,Espinosa Aunión Ruth,Soriano Castrejón Ángel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference53 articles.

1. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer;Goldhirsch;J Clin Oncol,2001

2. Fluorine-18 Fluorodeoxyglucose positron emission tomography-computed Tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.;Mghanga;Clin Breast Cancer,2013

3. Is 18 F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis;Wang;Breast Cancer Res Treat,2012

4. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: A determinant of outcome;Sataloff;J Am Coll Surg,1995

5. Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer;Honkoop;Br J Cancer,1998

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contrast-enhanced ultrasound features as a potential biomarker for the prediction of breast cancer recurrence;Ultraschall in der Medizin - European Journal of Ultrasound;2024-05-27

2. Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response;Journal of Clinical Medicine;2023-12-27

3. Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer;Cancers;2023-01-07

4. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid 18F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot study;Clinical Radiology;2022-10

5. 18F FDG PET/CT after Neoadjuvant Chemotherapy and Pathological Responses are Predictive Factors for Disease-Free Survival and Overall Survival in Patients with Locally Advanced Breast Cancer: A Prospective Study;International Journal of Hematology and Oncology;2022-09-30